Acribis Group Competitors and Similar CompaniesClear all

Acribis Group's competitors and similar companies include Y.S.P. SOUTHEAST ASIA HOLDING, Shandong Buchang Pharmaceuticals, Getz Pharma and Enseval.

	Acribis Group Acribis Group is a pharmaceutical company.	Y.S.P. SOUTHEAST ASIA HOLDING Y.S.P. Southeast Asia Holding is a company that manufactures pharmaceutical products.	Shandong Buchang Pharmaceuticals Shandong Buchang Pharmaceuticals (山东步长制药股份有限公司) is a company that specializes in medicine and pharmacy.	Getz Pharma Getz Pharma is a pharmaceutical company.	Enseval Enseval is a healthcare product distributor.
Founding Date	Founding Date 2012	Founding Date 1987	Founding Date 1993	Founding Date 1995	Founding Date 1973
Type	Type Private	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare pharma pharmacy	Tags Healthcare pharma pharmacy	Tags Healthcare pharma pharmacy	Tags Healthcare pharma pharmacy	Tags Healthcare pharma pharmacy
Locations	Locations Sant Cugat del Vallès, ES HQ	Locations Kuala Lumpur, MY HQ	Locations Xi'an, CN HQ	Locations Karachi, PK HQ Lagos, NG Pasig, PH Dubai, AE	Locations Jakarta, ID HQ
Employees	Employees 118% decrease	Employees 1,380	Employees 7,689	Employees 5,6991% increase	Employees 2,6001% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) RM365.1m (FY, 2025)	Revenue (est.) ¥11.7b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods RM172.4m (FY, 2025)	Cost of goods ¥4.4b (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit RM196.7m (FY, 2025)	Gross profit ¥7.3b (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income RM25.2m (FY, 2025)	Net income ¥192.3m (FY, 2025)	Net income N/A	Net income N/A